← back to search

Jinhui Liu

Delft University of Technology · NL
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, RNA modifications and cancer, and Cancer Immunotherapy and Biomarkers.
h-index
51
citations
11,609
works
787
NIH funding
primary concept
email

Recent publications

Exploring the Dynamic Changes of Intercellular Connections in Cervical Cancer: Insights From Transcriptomic Data Combined With Single-Cell Sequencing.
2026cited by 0position: contributordoi
Matrix stiffness enhances viability, migration, invasion and invadopodia formation of oral cancer cells via PI3K/AKT pathway in vitro
European journal of medical research 2025cited by 5position: middledoi
International Evidence‐Based Guidelines for Traditional Chinese Medicine Management of Allergic Rhinitis
Allergy 2025cited by 3position: middledoi
Single-Cell and Spatial Transcriptomics Explore Purine Metabolism-Related Prognostic Risk Model and Tumor Immune Microenvironment Modulation in Ovarian Cancer.
2025cited by 1position: contributordoi
Poly(ε‐Caprolactone)/Hydroxyapatite Nanofiber Scaffolds With <scp>FGF18</scp> for Cartilage Repair and Dual Modification of Apoptosis and Inflammation in Knee Osteoarthritis
Polymers for Advanced Technologies 2025cited by 0position: middledoi
Purine metabolism in tumorigenesis and its clinical implications.
2025cited by 0position: contributordoi
Spraying double-stranded RNA targets UDP-N-acetylglucosamine pyrophosphorylase in the control of Nilaparvata lugens
International Journal of Biological Macromolecules 2024cited by 21position: middledoi
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM
Journal of Neuro-Oncology 2024cited by 15position: middledoi
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.
2024cited by 13position: contributordoi
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis
Cell Death and Differentiation 2024cited by 12position: middledoi
Peceleganan Spray for the Treatment of Skin Wound Infections
JAMA Network Open 2024cited by 11position: middledoi
Multi‐Scenario Applications of Fluoro‐Free Super Liquid‐Repellent Particles Prepared Through Excluded Volume Effect
Advanced Functional Materials 2024cited by 9position: middledoi
Integration of machine learning for developing a prognostic signature related to programmed cell death in colorectal cancer.
2024cited by 7position: contributordoi
Prognostic and immunotherapeutic potential of regulatory T cell-associated signature in ovarian cancer.
2024cited by 6position: contributordoi
Prognostic and immunotherapeutic potential of regulatory T  <scp>cell‐associated</scp> signature in ovarian cancer
Journal of Cellular and Molecular Medicine 2024cited by 6position: middledoi
Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
2023cited by 114position: contributordoi
Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
2023cited by 67position: contributordoi
Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer.
2023cited by 61position: contributordoi
Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.
2023cited by 51position: contributordoi
A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients
Frontiers in Pharmacology 2023cited by 42position: lastdoi
A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients.
2023cited by 38position: contributordoi
Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.
2023cited by 35position: contributordoi
Identification of peripheral blood immune infiltration signatures and construction of monocyte-associated signatures in ovarian cancer and Alzheimer's disease using single-cell sequencing.
2023cited by 21position: contributordoi
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients.
2023cited by 12position: contributordoi
Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
2023cited by 11position: contributordoi
Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients.
2023cited by 10position: contributordoi
Using machine learning to identify patients at high risk of developing low bone density or osteoporosis after gastrectomy: a 10-year multicenter retrospective analysis
Journal of Cancer Research and Clinical Oncology 2023cited by 9position: middledoi
Using machine learning to identify patients at high risk of developing low bone density or osteoporosis after gastrectomy: a 10-year multicenter retrospective analysis.
2023cited by 8position: contributordoi
Identification of high-risk factors associated with mortality at 1-, 3-, and 5-year intervals in gastric cancer patients undergoing radical surgery and immunotherapy: an 8-year multicenter retrospective analysis.
2023cited by 8position: contributordoi
The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
Frontiers in Genetics 2023cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 16 papers (2021–2026)Yan Zhang · Chongqing Three Gorges Academy of Agricultural Sciences5 papers (2020–2021)Hongjun Zhu · Nantong University5 papers (2021–2022)Rui Geng · Jiangsu University5 papers (2022–2023)Jianling Bai · Nanjing Medical University5 papers (2022–2023)Qi Wang · The University of Texas MD Anderson Cancer Center5 papers (2023–2024)Chao Cheng · Dartmouth College3 papers (2023–2024)Hao Yu · Guangdong University of Technology3 papers (2022–2023)Mulong Du · Second Affiliated Hospital of Zhejiang University3 papers (2022–2022)Aiqun Chen · Nanjing Agricultural University3 papers (2018–2022)Miaomiao Cui · Nanjing Agricultural University3 papers (2018–2022)Songyun Zhao · Wenzhou Medical University3 papers (2023–2024)Guohua Xu · Sun Yat-sen University Cancer Center3 papers (2018–2022)Pengpeng Zhang · Shandong University3 papers (2023–2024)Jieyu Zhang · Nanchang University2 papers (2013–2014)Ying Ying · Sun Yat-sen University2 papers (2013–2014)Yuanyuan Wang · Anhui Medical University2 papers (2022–2022)Lishuo Zhang · Nanchang University2 papers (2022–2023)Xiaotian Huang · Central South University2 papers (2013–2014)Jianjian Liu · Nanjing Agricultural University2 papers (2019–2022)